Natural Psilocybin2024-05-15T11:29:12+02:00

Informed by nature
and guided by science

Informed
by nature
and guided
by science

Pioneering the use of natural psychedelics for mental health

We are a life science biotechnology company developing innovative, safe and effective psychedelic and nature-centred solutions for mental health.

Our key focus area is palliative care. In particular, Psyence is targeting the indications of anxiety and depression, and associated ailments, within the context of palliative care.

We develop natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Therapeutics is now housed in the NASDAQ listed entity Psyence Biomedical Ltd (NASDAQ:PBM).

We operate one of the first federally licensed ISO22000 certified psilocybin cultivation and production facilities in the world.

Our range of functional mushroom wellness products harness the power of adaptogens – non-toxic, non-psychoactive fungi used in ancient medicine for their stress relieving and general wellness benefits.

Learn More

Bringing together leaders in the business of medicine and science

Our scientific and medical team are experts in neurology and the development and commercialisation of pharmaceutical products. Our global executive team has extensive capital market and business building experience and a track record for creating shareholder value and achieving sustainable growth.

Our News

Our Global Footprint

Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and quoted on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions.

Our Global Footprint

Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and quoted on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions.

Our News

Contact Info

General inquiries — info@psyence.com

Media inquiries — media@psyence.com

Investor inquiries — ir@psyence.com

Tel: +1-416-477-1708

Address: 121 Richmond Street West, Penthouse Suite, 1300, Toronto ON M5H2K1, Canada

Sign Up To Our Newsletter

Sign Up To Receive Our Communications

By submitting this form, you are consenting to receive marketing emails from: Psyence Group Inc, 121 Richmond Street West, Penthouse Suite, 1300, Toronto ON M5H2K1 Canada You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
Psyence Biomed Wordmark

The  world’s first life science biotechnology company traded on the Nasdaq (NASDAQ:PBM) focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines.

Go to Top